Watch Ticker

Genprex, Inc. Common Stock

Go to Genprex, Inc. Common Stock Website

$0.25

0.00 (1.39%)

Live

Previous Close

$0.245

Day Range

$0.24 - $0.2593

Previous Day Range

$0.23 - $0.245

Market Cap

$7.7 million USD

Day Vol.

1.0 million

Previous Day Vol.

600741

Currency

USD

Primary Exchange

Nasdaq

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient po...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex's research collaborators will present positive preclinical data on the use of Reqorsa® Gene Therapy for treating Ras inhibitor resistant lung cancer, mesothelioma, and glioblastoma at the 2024 EORTC-NCI-AACR Symposium.

Related tickers: GNPX.

Read Full Article

Zacks Equity Research - Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up

Genprex (GNPX) gains 9.5% after expanding clinical study sites in the United States for the early to mid-stage study of lead candidate, Reqorsa, to treat lung cancer patients.

Related tickers: AZN, RHHBY, MRK, GNPX.

Read Full Article

Trending Tickers

Please sign in to view